Opinion
Video
Author(s):
In a focused discussion, Anne Chiang, MD, PhD, explores the sequencing of later-line therapies for limited-stage small cell lung cancer (LS-SCLC), emphasizing key factors to consider when making treatment decisions for patients who have progressed on initial therapy.
Video content above is prompted by the following questions:
2 Commerce Drive
Cranbury, NJ 08512